companydata.dkPharmyn ApS: Financial statements 2025
CVR: 37133892
Pharmyn ApS (CVR 37133892) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -12,457 and a net result of DKK -12,409 compared with DKK 6,701 the year before. Equity amounted to DKK 18,662. The solvency ratio was 75.1%.
- Gross Profit
- -12,457 kr.
- Profit/Loss
- -12,409 kr.
- Equity
- 18,662 kr.
- Total Assets
- 24,851 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -12 t. | -12 t. | 19 t. | 0 |
| 2024 | - | 7 t. | 7 t. | 31 t. | 0 |
| 2023 | - | 10 t. | 10 t. | 24 t. | 0 |
| 2022 | - | -20 t. | -20 t. | 14 t. | 0 |
| 2021 | - | 12 t. | 12 t. | 34 t. | 0 |
Find more companies like Pharmyn ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
Pharmyn ApS has published its annual report for 2024. Gross profit came to DKK 6,544, and the net result was DKK 6,701.
About Pharmyn ApS
Pharmyn ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Henrik Lund Uth. The company is owned by Henrik Lund Uth. In 2025, the company reported a gross profit of DKK -12,457 and a net result of DKK -12,409 compared with DKK 6,701 the year before. Equity amounted to DKK 18,662.